S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)

Quest Diagnostics (DGX) ESG Score & Sustainability Data

$125.91
-1.07 (-0.84%)
(As of 04/18/2024 ET)

Key ESG Takeaways for Quest Diagnostics

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Quest Diagnostics. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Quest Diagnostics seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Private clinical drug testing, Private genetic testing services, and Private oncology diagnostics services products.
  • Quest Diagnostics uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Private chronic disease diagnostics, Private hemostasis diagnostics services, Private HIV resistance diagnostics services, Private clinical drug testing, and Private endocrine testing products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Private oncology diagnostics services business, Quest Diagnostics would improve its net impact ratio by 0 percentage points.

DGX Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.5%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+76.7%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+70.0%
Society First
Value set that emphasizes society impacts over other impacts.
+53.1%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+85.1%
Health First
Value set that emphasizes health impacts over other impacts.
+88.4%

Quest Diagnostics ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.35
+1.35
+1.75
+1.75
+0.11
+0.11
-0.01
0.00
+0.00
-0.04
+0.04
+0.07
+0.02
+0.02
+1.76
+1.76
-0.00
+0.00
+0.00
-1.48
-1.48
-0.12
+3.19
+3.31
-0.02
+0.31
+0.33
0.00
+0.00
-0.01
+0.10
+0.10
-0.00
+0.19
+0.19
-0.20
-0.19
+0.00
-0.03
-0.03
+0.00
-0.02
-0.02
+0.00
-0.01
-0.01
+0.00
-0.36
-0.36
+0.00

Upright Model Version 0.7.0
ESG Data Last Updated: December 8, 2022

About Upright's Net Impact Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Quest Diagnostics ESG Score - Frequently Asked Questions

How is Quest Diagnostics doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Quest Diagnostics has a net impact ratio of 74.5%, indicating an overall positive sustainability impact. Quest Diagnostics seems to create the most significant positive value in the categories of Physical diseases, Creating knowledge, and Taxes. Quest Diagnostics uses resources or causes negative impacts mostly in the categories of Scarce human capital, Waste, and GHG emissions. Learn more on the sustainability of Quest Diagnostics.


More ESG Stocks and Research Tools

This page (NYSE:DGX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners